Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

14.08

-0.45 (-3.10%)

At close: Apr 16, 2026, 4:00 PM EDT

14.00

-0.08 (-0.57%)

Pre-market: Apr 17, 2026, 5:54 AM EDT

Adaptive Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-59.46	-159.6	-225.3	-200.37	-207.3
Depreciation & Amortization	17.83	19.26	22.23	20.92	13.95
Stock-Based Compensation	51.48	53.61	62.91	55.48	43.25
Other Adjustments	1.92	8.97	30.02	11.57	14.18
Change in Receivables	-8.65	-3.74	2.03	-22.65	-7.36
Changes in Inventories	-1	5.37	-2.84	0.82	-5.2
Changes in Accounts Payable	0.67	0.67	-5.41	7.11	3.94
Changes in Unearned Revenue	-36.75	-10.48	-29.29	-56.5	-57.73
Changes in Other Operating Activities	-12.04	-9.28	-10.68	-0.33	9.53
Operating Cash Flow	-45.99	-95.21	-156.32	-183.95	-192.73
Capital Expenditures	-2.96	-3.66	-10.7	-16.35	-61.75
Purchases of Investments	-181.71	-244.26	-429.56	-278.78	-316.54
Proceeds from Sale of Investments	222.62	325.71	569.9	298.03	559.5
Investing Cash Flow	37.95	77.79	129.65	2.91	181.21
Issuance of Common Stock	17.88	0.24	2.25	7.89	26.72
Net Common Stock Issued (Repurchased)	17.88	0.24	2.25	7.89	26.72
Other Financing Activities	12.52	-	-	124.38	0.43
Financing Cash Flow	30.4	0.24	2.25	132.27	27.15
Net Cash Flow	22.37	-17.18	-24.43	-48.78	15.63
Free Cash Flow	-48.95	-98.88	-167.02	-200.29	-254.47
FCF Margin	-17.67%	-55.25%	-98.09%	-108.09%	-164.87%
Free Cash Flow Per Share	-0.32	-0.67	-1.16	-1.41	-1.81
Levered Free Cash Flow	-93.75	-157.61	-261.93	-244.52	-304.53
Unlevered Free Cash Flow	-91.37	-160.67	-263.72	-244.51	-306.21

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q